Skip to main content
. 2016 Mar 9;26(11):4089–4097. doi: 10.1007/s00330-016-4259-9

Fig. 5.

Fig. 5

In vivo MRI analysis of tumours injected with vectors. T2*-weighted imaging of tumours shows remarkable hypointensity in A549 tumours, but not U2OS tumours, injected with Lenti-hTERT-Fth1-3FLAG-Puro and in A549 and U2OS tumours injected with Lenti-CMV-Fth1-3FLAG-Puro. No apparent signal loss in T2-weighted images of the tumours was observed. hTERT Lenti-hTERT-Fth1-3FLAG-Puro-injected tumours, CMV Lenti-CMV-Fth1-3FLAG-Puro-injected tumours, WT wild-type tumours, PBS PBS-injected tumours